Supriya Lifescience Limited (SUPRIYA) Share Analysis
NSE · Healthcare · Pharmaceuticals
Supriya Lifescience Limited (NSE: SUPRIYA) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹910.00, market capitalisation ₹73,23,93,47,200 Cr, P/E 36.92.
Get the AI verdict on SUPRIYA: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
SUPRIYA price and valuation
- Share price
- ₹910.00
- Market cap
- ₹73,23,93,47,200 Cr
- P/E ratio
- 36.92
- P/B ratio
- 6.12
- EPS
- ₹24.65
- Book value per share
- ₹148.77
- Dividend yield
- 11%
SUPRIYA profitability and growth
- ROE
- -
- ROCE
- -
- Debt to equity
- 0
- Revenue growth (3 yr)
- -
- Revenue growth (5 yr)
- -
- Profit growth (3 yr)
- -
- Profit growth (5 yr)
- -
SUPRIYA 52-week range
- 52-week high
- ₹1,085.00
- 52-week low
- ₹545.50
- Face value
- -
SUPRIYA shareholding pattern
- Promoters
- 68.3%
- FIIs
- 6.18%
- DIIs
- 5.3%
- Public
- 20.21%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.